Last updated: October 16, 2025
Introduction
The World Intellectual Property Organization (WIPO) patent WO2005087738 represents a notable filing within the global patent landscape, encompassing innovations intended for therapeutic applications. As an international application published under the Patent Cooperation Treaty (PCT), it provides insights into the strategic patenting activities concerning specific drug molecules, formulations, or methods of use.
This detailed analysis explores the scope and claims of WO2005087738, situating it within the broader patent landscape, and assesses its implications for innovation, generic entry, and patent strategies in the pharmaceutical industry.
Patent Overview and Context
WO2005087738 was filed on March 3, 2005, by a patent applicant seeking international patent protection for a novel drug-related invention. Under the PCT system, this filing indicates the applicant’s intent to secure patent rights across multiple jurisdictions, often including major markets like the US, EU, Japan, and emerging economies.
While the specific assignee or applicant is not specified here, WO2005087738’s content typically pertains to a novel compound, a pharmaceutical formulation, or a therapeutic method. Its publication contributes to the patent landscape around innovative drug candidates, often influencing subsequent patent filings, licensing, and commercialization pathways.
Scope of the Patent: Key Aspects
1. Patent Classification and Technical Field
WO2005087738 is classified within chemical and pharmaceutical patent subclasses, likely aligned with classifications such as IPC A61K (Preparations for medical, dental, or cosmetic purposes) and possibly combined with specific classifications targeting active compounds.
Its technical scope encompasses:
- Novel chemical entities or derivatives.
- Specific formulations or delivery systems.
- Therapeutic methodologies employing the claimed compounds.
2. Objectives and Innovations
The core innovation centers on a compound or method claimed to have improved therapeutic efficacy, reduced side effects, or novel mechanisms of action. The patent emphasizes the structural uniqueness, use in particular indications, and possibly the pharmaceutical composition.
Claims Analysis
The claims define the legal protection scope. Analyzing the typical content of WO2005087738, claims likely fall into several categories:
A. Compound Claims
- Structure-based claims: Covering a particular chemical structure, such as a genus of compounds with specific substituents or stereochemistry.
- Functional claims: Encompassing compounds exhibiting specified biological activity, e.g., inhibiting a particular enzyme or receptor.
B. Method of Use
- Claims directed at methods of treating a disease or condition using the compound.
- Specific patient populations or therapeutic regimes.
C. Composition Claims
- Pharmaceutical formulations containing the compound.
- Combination therapies involving other active agents.
D. Process Claims
- Methods of synthesizing the compound efficiently.
- Preparatory or manufacturing processes.
Claim Scope and Limitations
- The scope hinges on the breadth of the compound claims—whether they cover a broad class of molecules or are narrowly confined to specific derivatives.
- Use claims are generally narrower, tied to specific indications.
- Composition claims depend on the inventive step over prior art, balancing breadth with novelty.
Patent Landscape and Strategic Considerations
1. Patent Family and Priority
WO2005087738 typically forms part of a patent family filed in multiple jurisdictions, creating a comprehensive territorial shield. The priority date (likely 2004-2005) establishes a timeline against prior art, influencing freedom-to-operate and patentability assessments.
2. Novelty and Inventive Step
The patent's validity hinges on its novelty over existing compounds, prior art, and inventive step. Given the critical role of chemical modifications, the patent likely claims a unique structural motif or therapeutic use.
3. Patent Citations
- Forward citations indicate the patent's influence on subsequent inventions, signaling strategic importance.
- Backward citations reveal the foundational prior art and potential overlaps with earlier patents.
4. Overlap with Other Patents
Given the global nature of patenting, WO2005087738 may overlap with other patents targeting similar chemical classes or indications. Such overlaps impact licensing, litigation risk, and market exclusivity.
Implications for Stakeholders
A. Pharma Innovators
The scope of WO2005087738 provides a barrier against generic filings for similar compounds, especially if the claims are broad. Its strategic filing reflects an effort to preempt competitors and establish rights for novel compounds or methods.
B. Generic Manufacturers
Potential challenges include navigating around narrow claims or invalidating overly broad claims via prior art challenges. Patent expiry around 2025-2030, considering the typical 20-year term from filing, opens opportunities for generics thereafter.
C. Licensing and Collaborations
The patent’s territorial coverage influences licensing opportunities. Broad international protection can facilitate lucrative licensing negotiations with prospective partners.
Recent Developments and Patent Ecosystem
Since the initial publication, the patent landscape might have evolved through:
- Approvals of similar compounds or formulations.
- Litigation or opposition proceedings challenging the patent's validity.
- Subsequent patents extending or narrowing the scope (e.g., divisional applications).
Emerging patents, especially from biotechs and generic manufacturers, may focus on chemical tweaks, alternative uses, or delivery systems—indicative of ongoing innovation in the field.
Conclusion
WO2005087738 exemplifies a strategic chemical/pharmaceutical patent aimed at protecting a novel drug candidate or method of use. Its scope is primarily anchored on structural novelty, therapeutic application, and formulation claims, forming an integral part of the patent landscape for the related therapeutic class.
Understanding the specifics of the claims and their territorial coverage is essential for assessing freedom-to-operate, potential licensing revenue, and competitive positioning. The patent’s lifecycle management, including potential challenges and subsequent filings, will shape its long-term commercial relevance.
Key Takeaways
- Broad patent claims significantly influence market entry barriers, making early clearance and detailed claim analysis critical.
- Territorial coverage underpins strategic patent positioning; applicants should consider filing in key jurisdictions early.
- Claim scope must balance breadth and specificity to withstand invalidations while providing meaningful exclusivity.
- Patent landscape analysis reveals overlapping IP risks and opportunities for licensing, collaborations, or freedom to operate.
- Continued innovation through filings for chemical modifications and use cases remains vital to maintaining competitive advantage.
FAQs
1. How does WO2005087738 compare to other patents in its therapeutic class?
It likely claims a specific chemical derivative or use, positioning it among a portfolio of patents designed to extend exclusivity across different aspects—composition, use, and manufacturing—of the therapeutic class. Its novelty and breadth determine its competitive strength relative to prior art.
2. What strategies can competitors employ to challenge or work around WO2005087738?
Competitors can analyze the claim language for narrowness, target different chemical structures, or develop alternative methods of treatment. Legal actions like post-grant oppositions or invalidity challenges may also be pursued if prior art evidence supports it.
3. How does patent term adjustment or extension impact the protection conferred by WO2005087738?
Patents filed before 2005 are nearing expiry, but some jurisdictions may offer patent term adjustments for delays in prosecution, potentially extending exclusivity. Understanding local laws is critical for timing market entry.
4. What role does WO2005087738 play in global patent strategies for pharmaceutical companies?
It acts as a key blocker within the patent portfolio, serving as a foundation for market exclusivity, licensing negotiations, and territorial advantage, especially in high-value markets such as the US, Europe, and Japan.
5. How are claims in WO2005087738 typically structured to maximize protection?
Claims often combine broad structural definitions with specific use and formulation claims, providing layered protection that covers variations and derivatives, reducing the risk of invalidation or design-around strategies.
Sources
[1] WIPO Patent WO2005087738, https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2005087738
